Follow
Jeffrey L. Schaal
Jeffrey L. Schaal
CSO, Cereius Inc.
Verified email at cereius.io
Title
Cited by
Cited by
Year
Injectable tissue integrating networks from recombinant polypeptides with tunable order
S Roberts, TS Harmon, JL Schaal, V Miao, KJ Li, A Hunt, Y Wen, TG Oas, ...
Nature materials 17 (12), 1154-1163, 2018
1442018
One-week glucose control via zero-order release kinetics from an injectable depot of glucagon-like peptide-1 fused to a thermosensitive biopolymer
KM Luginbuhl, JL Schaal, B Umstead, EM Mastria, X Li, S Banskota, ...
Nature biomedical engineering 1 (6), 1-14, 2017
1112017
Injectable polypeptide micelles that form radiation crosslinked hydrogels in situ for intratumoral radiotherapy
JL Schaal, X Li, E Mastria, J Bhattacharyya, MR Zalutsky, A Chilkoti, W Liu
Journal of Controlled Release 228, 58-66, 2016
792016
Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity
EM Mastria, LY Cai, MJ Kan, X Li, JL Schaal, S Fiering, MD Gunn, ...
Journal of Controlled Release 269, 364-373, 2018
592018
Spatiotemporally photoradiation-controlled intratumoral depot for combination of brachytherapy and photodynamic therapy for solid tumor
R Mukerji, J Schaal, X Li, J Bhattacharyya, D Asai, MR Zalutsky, A Chilkoti, ...
Biomaterials 79, 79-87, 2016
442016
Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers
Y Feng, R Meshaw, D McDougald, Z Zhou, XG Zhao, SA Jannetti, ...
Scientific reports 12 (1), 1-13, 2022
212022
Heuristics for the optimal presentation of bioactive peptides on polypeptide micelles
J Wang, S Saha, JL Schaal, P Yousefpour, X Li, A Chilkoti
Nano Letters 19 (11), 7977-7987, 2019
62019
2.5 Elastin-Like Polypeptides
S Roberts, S Costa, J Schaal, JR Simon, M Dzuricky, FG Quiroz, A Chilkoti
Elsevier, 2017
62017
Genetically Engineered Nanoparticles of Asymmetric Triblock Polypeptide with a Platinum (IV) Cargo Outperforms a Platinum (II) Analog and Free Drug in a Murine Cancer Model
S Saha, S Banskota, J Liu, N Zakharov, M Dzuricky, X Li, P Fan, ...
Nano Letters 22 (14), 5898-5908, 2022
42022
Biopolymer β-brachytherapy delivered concomitantly with systemic paclitaxel outperforms traditional x-ray radiation to induce complete regression in multiple pancreatic tumor …
JL Schaal, J Bhattacharyya, X Li, S Banskota, J Brownstein, D Kirsch, ...
Cancer Research 78 (13_Supplement), 5831-5831, 2018
12018
Next-generation brachytherapy: a preclinical study of a thermally stabilized biopolymer gel for delivering intratumoral radionuclide therapy in a pancreatic tumor mouse model
JL Schaal, W Liu, A Chilkoti, X Li, E Mastria, MR Zalutsky
Cancer Research 75 (15_Supplement), 1809-1809, 2015
12015
LIQUIDLY INJECTABLE, SELF-STABILIZING BIOPOLYMERS FOR THE DELIVERY OF RADIONUCLIDE
A Chilkoti, JL Schaal, W Liu
US Patent App. 17/294,368, 2022
2022
Thermally-Responsive Biopolymer Depots for the Delivery of High-Dose, β-Radionuclide Brachytherapy in the Treatment of Prostate and Pancreatic Cancer
JL Schaal
Duke University, 2018
2018
SU‐F‐T‐10: Validation of ELP Dosimetry Using PRESAGE Dosimeter: Feasibility Test and Practical Considerations
K Lambson, K Lafata, J Schaal, D Miles, S Yoon, W Liu, M Oldham, J Cai
Medical Physics 43 (6Part12), 3463-3463, 2016
2016
Evaluation of the antitumoral efficacy and toxicity of injectable, polymeric radionuclide seeds in a noninvasive preclinical prostate tumor model.
JL Schaal, W Liu, X Li, M Zalutsky, A Chilkoti
Cancer Research 73 (8_Supplement), 5615-5615, 2013
2013
Supplemental Information for
SA Zhao, RE Reiman, E Pippen, R Marjoram, JL Schaal, G Vaidyanathan, ...
Evaluation of the Anti-tumoral Efficacy and Toxicity of Injectable, ELP Radionuclide Depots in a Non-Invasive Prostate Tumor Model
J Schaal, W Liu, X Li, M Zalutsky, A Chilkoti
The system can't perform the operation now. Try again later.
Articles 1–17